Decreased Tonic Inhibition in Cerebellar Granule Cells Causes Motor Dysfunction in a Mouse Model of Angelman Syndrome

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Science Translational Medicine

• Publication date

  2012-12-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/scitranslmed.3004655PMID 23220633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Angelman syndrome protein Ube3a regulates synapse development by ubiquitinating Tkv in Drosophila

  2013cited by this paper
• APCCdh1 mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity

  2011cited by this paper
• The Cavβ subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels

  2011cited by this paper
• Alterations in Intrinsic Membrane Properties and the Axon Initial Segment in a Mouse Model of Angelman Syndrome

  2011cited by this paper
• Bidirectional control of BK channel open probability by CAMKII and PKC in medial vestibular nucleus neurons.

  2011cited by this paper
• Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

  2010cited by this paper
• Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.

  2010cited by this paper
• The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.

  2010cited by this paper
• Reduction of transforming growth factor‐β type II receptor is caused by the enhanced ubiquitin‐dependent degradation in human renal cell carcinoma

  2010cited by this paper
• Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a

  2010cited by this paper
• Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.

  2010cited by this paper
• Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex.

  2010cited by this paper
• Enhanced tonic GABAA inhibition in typical absence epilepsy

  2009cited by this paper
• Ube3a is required for experience-dependent maturation of the neocortex

  2009cited by this paper
• Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb

  2009cited by this paper
• Inhibition of thalamic excitability by 4,5,6,7‐tetrahydroisoxazolo[4,5‐c]pyridine‐3‐ol: a selective role for δ‐GABAA receptors

  2009cited by this paper
• Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors.

  2008cited by this paper
• [(11)C]flumazenil positron emission tomography analyses of brain gamma-aminobutyric acid type A receptors in Angelman syndrome.

  2008cited by this paper
• Concentrative Export from the Endoplasmic Reticulum of the γ-Aminobutyric Acid Transporter 1 Requires Binding to SEC24D*

  2007cited by this paper
• Plasma and CNS concentrations of Gaboxadol in rats following subcutaneous administration.

  2007cited by this paper
• Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function

  2007cited by this paper
• The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.

  2007cited by this paper
• Postnatal development and kinetics of [3H]gaboxadol binding in rat brain: in vitro homogenate binding and quantitative autoradiography.

  2007cited by this paper
• Synaptic destabilization by neuronal Nogo-A

  2007cited by this paper
• Deletion of the GABAA Receptor α1 Subunit Increases Tonic GABAA Receptor Current: A Role for GABA Uptake Transporters

  2006cited by this paper
• Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene.

  2006cited by this paper
• Contributions of the GABAA Receptor α6 Subunit to Phasic and Tonic Inhibition Revealed by a Naturally Occurring Polymorphism in the α6 Gene

  2006cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• Enhanced Mdm2 activity inhibits pRB function via ubiquitin‐dependent degradation

  2005cited by this paper
• Fast cerebellar oscillation associated with ataxia in a mouse model of Angelman syndrome.

  2005cited by this paper
• GABA Transporter Deficiency Causes Tremor, Ataxia, Nervousness, and Increased GABA-Induced Tonic Conductance in Cerebellum

  2005cited by this paper
• Developmental expression of GABA transporter-1 and 3 during formation of the GABAergic synapses in the mouse cerebellar cortex.

  2005cited by this paper
• Integration of quanta in cerebellar granule cells during sensory processing

  2004cited by this paper
• Interaction of neuron‐specific K+‐Cl− cotransporter, KCC2, with brain‐type creatine kinase

  2004cited by this paper
• Oligomerization of the γ-Aminobutyric Acid Transporter-1 Is Driven by an Interplay of Polar and Hydrophobic Interactions in Transmembrane Helix II*

  2004cited by this paper
• Diversity of inhibitory neurotransmission through GABA(A) receptors.

  2004cited by this paper
• Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency.

  2004cited by this paper
• Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis.

  2003cited by this paper
• Derangements of Hippocampal Calcium/Calmodulin-Dependent Protein Kinase II in a Mouse Model for Angelman Mental Retardation Syndrome

  2003cited by this paper
• Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase Nedd4‐2 and the serum and glucocorticoid‐inducible kinase isoforms SGK1/3 and protein kinase B

  2003cited by this paper
• Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance.

  2003cited by this paper
• Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis.

  2003cited by this paper
• Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

  2002cited by this paper
• Active Contribution of Dendrites to the Tonic and Trimodal Patterns of Activity in Cerebellar Purkinje Neurons

  2002influential reference
• Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors

  2002cited by this paper
• Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex.

  2002cited by this paper
• Trace fear conditioning involves hippocampal α5 GABAA receptors

  2002cited by this paper
• Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.

  2002cited by this paper
• Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.

  2002cited by this paper
• Distinct phenotypes distinguish the molecular classes of Angelman syndrome

  2001cited by this paper
• Glial transporters for glutamate, glycine, and GABA: II. GABA transporters

  2001cited by this paper
• Adaptive regulation of neuronal excitability by a voltage- independent potassium conductance

  2001cited by this paper
• Glial transporters for glutamate, glycine and GABA I. Glutamate transporters

  2001cited by this paper
• Spillover-Mediated Transmission at Inhibitory Synapses Promoted by High Affinity α6 Subunit GABAA Receptors and Glomerular Geometry

  1998cited by this paper
• Spillover-mediated transmission at inhibitory synapses promoted by high affinity alpha6 subunit GABA(A) receptors and glomerular geometry.

  1998cited by this paper
• Immunoreactivity for the GABA transporter-1 and GABA transporter-3 is restricted to astrocytes in the rat thalamus. A light and electron-microscopic immunolocalization.

  1998cited by this paper
• Segregation of Different GABAA Receptors to Synaptic and Extrasynaptic Membranes of Cerebellar Granule Cells

  1998cited by this paper
• Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

  1998influential reference
• Adverse Effects of Vigabatrin in Angelman Syndrome

  1998cited by this paper
• Development of Action Potential‐dependent and Independent Spontaneous GABAA Receptor‐mediated Currents in Granule Cells of Postnatal Rat Cerebellum

  1997influential reference
• Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons

  1997influential reference
• Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors.

  1996cited by this paper
• UBE3A/E6-AP mutations cause Angelman syndrome

  1996cited by this paper
• Ion Binding and Permeation at the GABA Transporter GAT1

  1996cited by this paper
• Whole‐cell and single‐channel currents activated by GABA and glycine in granule cells of the rat cerebellum.

  1995cited by this paper
• Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation.

  1995cited by this paper
• Angelman syndrome: Consensus for diagnostic criteria

  1995cited by this paper
• Quantitative autoradiographic characterization of the binding of [3H]tiagabine (NNC 05-328) to the GABA uptake carrier.

  1994cited by this paper
• A modified method for lead staining of thin sections.

  1968cited by this paper
• Abstract / Poster: 2-6 Clinical Meg: Pain and Somatosensory Function Poster: 2-6 Clinical Meg: Pain and Somatosensory Function 2-6-1: Aberrant Somatosensory Evoked Responses Imply Gabaergic Dysfunction in Angelman Syndrome 2-6-2: Somatosensory Evoked Magnetic Fields in Patients with Tongue Sensory D

  year unknowncited by this paper

• GABA transporter 1 is a promising drug target for CUL4B mutation-associated epilepsy

  2025influential citation
• CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice

  2024cites this paper
• A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring

  2024cites this paper
• Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome.

  2024cites this paper
• Precision Medicine in Angelman Syndrome

  2024cites this paper
• Unravelling the Cerebellar Involvement in Autism Spectrum Disorders: Insights into Genetic Mechanisms and Developmental Pathways

  2024cites this paper
• Forestwalk: A Machine Learning Workflow Brings New Insights Into Posture and Balance in Rodent Beam Walking

  2024cites this paper
• A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring

  2024cites this paper
• Multiscale spatio-temporal dynamics of UBE3A gene in brain physiology and neurodevelopmental disorders.

  2024cites this paper
• Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study.

  2023cites this paper
• Imbalanced expression of cation-chloride cotransporters as a potential therapeutic target in an Angelman syndrome mouse model

  2023influential citation
• Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology

  2023cites this paper
• A novel combination treatment for fragile X syndrome predicted using computational methods

  2023cites this paper
• UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies

  2023cites this paper
• Translational research for the development of treatment of patients with neurogenetic diseases: An important step for Angelman syndrome.

  2023cites this paper
• Stem cell models of Angelman syndrome

  2023cites this paper
• Pharmacotherapeutic management of seizures in patients with Angleman Syndrome

  2022cites this paper
• Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism

  2022cites this paper
• The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models

  2022cites this paper
• Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation.

  2022cites this paper
• The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome

  2022cites this paper
• Neurexin1α knockout rats display oscillatory abnormalities and sensory processing deficits back-translating key endophenotypes of psychiatric disorders

  2022cites this paper
• A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets

  2022cites this paper
• α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials

  2022cites this paper
• Delta power robustly predicts cognitive function in Angelman syndrome

  2021cites this paper
• The role of GABAergic signalling in neurodevelopmental disorders

  2021cites this paper
• Flurothyl-induced seizure paradigm revealed higher seizure susceptibility in middle-aged Angelman syndrome mouse model.

  2021cites this paper
• UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome

  2021cites this paper
• Molecular determinants underlying DS2 activity at δ-containing GABAA receptors

  2021cites this paper
• Variance in the pathophysiological impact of the hemizygosity of gamma-aminobutyric acid type A receptor subunit genes between Prader-Willi syndrome and Angelman syndrome.

  2021cites this paper
• Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am−/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade

  2021cites this paper
• Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome

  2021cites this paper
• Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the Ube3a Deletion Rat Model of Angelman Syndrome

  2021cites this paper
• Induced pluripotent stem cells for modeling Angelman syndrome

  2021cites this paper
• Therapies in preclinical and clinical development for Angelman syndrome

  2021cites this paper
• ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration

  2021cites this paper
• Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model.

  2020cites this paper
• Properties of beta oscillations in Dup15q syndrome

  2020cites this paper
• The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders

  2020cites this paper
• An Astrocytic Influence on Impaired Tonic Inhibition in Hippocampal CA1 Pyramidal Neurons in a Mouse Model of Rett Syndrome

  2020cites this paper
• Angelman syndrome: from mouse models to therapy.

  2020influential citation
• Angelman syndrome: a journey through the brain

  2020cites this paper
• Activity- and sleep-dependent regulation of tonic inhibition by Shisa7

  2020cites this paper
• The STARS Phase 2 Study

  2020cites this paper
• Short-latency somatosensory-evoked potentials demonstrate cortical dysfunction in patients with Angelman syndrome

  2020cites this paper
• Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome

  2020cites this paper
• Multimodal GABAA receptor functions in the development of the central nervous system

  2020cites this paper
• Deficits in higher visual area representations in a mouse model of Angelman syndrome

  2020cites this paper
• Epilepsy in Angelman syndrome: A scoping review.

  2020influential citation
• Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy.

  2020cites this paper
• Behavioral Evaluation of Angelman Syndrome Mice at Older Ages.

  2019influential citation
• Neurexophilin4 is a selectively expressed α-neurexin ligand that modulates specific cerebellar synapses and motor functions

  2019cites this paper
• Synthesis and Pharmacological Evaluation of [C-11]4-Methoxy-N-[2-(thiophen-2-yl) imidazo[1,2-a] pyridin-3-yl]benzamide as a Brain Penetrant PET Ligand Selective for the delta-Subunit-Containing gamma-Aminobutyric Acid Type A Receptors

  2019cites this paper
• The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions

  2019cites this paper
• Synthesis and Pharmacological Evaluation of [11C]4-Methoxy-N-[2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide as a Brain Penetrant PET Ligand Selective for the δ-Subunit-Containing γ-Aminobutyric Acid Type A Receptors

  2019cites this paper
• The ubiquitin proteasome pathway in neuropsychiatric disorders.

  2019cites this paper
• Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI‐189

  2019cites this paper
• UBE3A regulates the transcription of IRF, an antiviral immunity.

  2019cites this paper
• Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes.

  2019cites this paper
• The role of the GABAA receptor δ subunit domains on agonist binding kinetics

  2019cites this paper
• Conditioned Aversion and Neuroplasticity Induced by a Superagonist of Extrasynaptic GABAA Receptors: Correlation With Activation of the Oval BNST Neurons and CRF Mechanisms

  2019cites this paper
• Towards an understanding of Angelman syndrome in mice studies

  2019influential citation
• Modulation of GABA A receptor function and sleep

  2018cites this paper
• MHC class I in dopaminergic neurons suppresses relapse to reward seeking

  2018cites this paper
• Neurobiological bases of autism–epilepsy comorbidity: a focus on excitation/inhibition imbalance

  2018cites this paper
• Taurine Administration Recovers Motor and Learning Deficits in an Angelman Syndrome Mouse Model

  2018cites this paper
• Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders

  2018cites this paper
• Identification of spatiotemporal gait parameters and pressure‐related characteristics in children with Angelman syndrome: A pilot study

  2018cites this paper
• Control of motor coordination by astrocytic tonic GABA release through modulation of excitation/inhibition balance in cerebellum

  2018cites this paper
• Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome

  2018cites this paper
• Differential Methylation of H3K79 Reveals DOT1L Target Genes and Function in the Cerebellum In Vivo

  2018cites this paper
• Cellular And Molecular Insight Into Autonomic Function And Dysfunction

  2018cites this paper
• Subcellular organization of UBE3A in human cerebral cortex

  2018cites this paper
• Pattern Recognition Receptors, Immune Proteins, and NF-κB Signaling Regulate Behaviors Associated With Aging Phenotypes

  2017cites this paper
• Cerebellar and Striatal Pathologies in Mouse Models of Autism Spectrum Disorder.

  2017cites this paper
• Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders.

  2017cites this paper
• The Angelman Approach : hacking DNA to treat a rare disease

  2017cites this paper
• Autism genetics – an overview

  2017cites this paper
• Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis

  2017cites this paper
• Pharmacological therapies for Angelman syndrome

  2017cites this paper
• INTERVENTION TO EXTRASYNAPTIC GABAA RECEPTORS FOR SYMPTOM RELIEF IN MOUSE MODELS OF RETT SYNDROME

  2017cites this paper
• Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model

  2017influential citation
• Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells

  2017cites this paper
• Genetically Dissecting Cortical Neurons Involved in Epilepsy in Angelman Syndrome.

  2016cites this paper
• Reduced tonic inhibition after stroke promotes motor performance and epileptic seizures

  2016cites this paper
• The Effects of Synthetic and Dietary Therapeutics on Learning, Memory, Motor Coordination, and Seizure in an Angelman Syndrome Mouse Model

  2016influential citation
• Angelman syndrome: Current and emerging therapies in 2016

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Potential therapeutic approaches for Angelman syndrome

  2016influential citation
• A Behavioral and Molecular Approach for Understanding Angelman Syndrome

  2016cites this paper
• Loss of UBE3A from TH-expressing neurons suppresses GABA co-release and enhances VTA-NAc optical self-stimulation

  2016cites this paper
• Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome

  2016cites this paper
• GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.

  2016cites this paper
• Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model.

  2016cites this paper
• RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.

  2016cites this paper
• Modeling Neurodevelopmental Disorders Involving Genomic Imprinting at Human Chromosome 15q11-q13 Using iPSC and CRISPR/Cas9 Technology

  2016cites this paper
• Towards targeted therapy for Angelman syndrome

  2016cites this paper
• Variation in Dube3a expression affects neurotransmission at the Drosophila neuromuscular junction

  2015cites this paper
• Maternal Ube3a is Required for Neurotypical Motivational Drive and GABA co-release

  2015cites this paper
• Minocycline Treatment and the Necessity to Develop a Novel Outcome Measure for Children with Angelman Syndrome

  2015cites this paper